2022
DOI: 10.1002/brb3.2686
|View full text |Cite
|
Sign up to set email alerts
|

Neuroprotective effects of mild hypothermia against traumatic brain injury by the involvement of the Nrf2/ARE pathway

Abstract: Background Traumatic brain injury (TBI) is the leading cause of death and disability worldwide. Mild hypothermia (32–35°C) has been found to show neuroprotective effects against TBI. However, the specific mechanism is still elusive. In the current study, we explored the relationship between oxidative damage after TBI and treatment with mild hypothermia as well as the underlying molecular mechanisms. Methods We used the closed cortex injury model to perform the brain injury and a temperature monitoring and cont… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 52 publications
0
7
0
Order By: Relevance
“…Additionally, applying a combination of pharmacologic and non-pharmacologic interventions is a possible means to address the pathophysiology of TBI and TBI-associated secondary damage, as non-pharmacologic interventions can target similar mechanisms of secondary injury through different targets in a multimodal approach to TBI treatment. For example, a hypothetical combination of mild therapeutic hypothermia and a free radical scavenger would target oxidative stress through decreasing ROS/RNS and upregulating anti-oxidative enzymes, potentially impacting oxidative stress at the hyperacute and early acute time periods [ 61 , 147 ]. While non-pharmacologic interventions are an appealing avenue for treatment of TBI, the mechanisms that underlie these interventions are not always well characterized.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, applying a combination of pharmacologic and non-pharmacologic interventions is a possible means to address the pathophysiology of TBI and TBI-associated secondary damage, as non-pharmacologic interventions can target similar mechanisms of secondary injury through different targets in a multimodal approach to TBI treatment. For example, a hypothetical combination of mild therapeutic hypothermia and a free radical scavenger would target oxidative stress through decreasing ROS/RNS and upregulating anti-oxidative enzymes, potentially impacting oxidative stress at the hyperacute and early acute time periods [ 61 , 147 ]. While non-pharmacologic interventions are an appealing avenue for treatment of TBI, the mechanisms that underlie these interventions are not always well characterized.…”
Section: Discussionmentioning
confidence: 99%
“…30,32,34 Similarly, hypothermia, HBO, and DC reduce edema and ICP. 27,32,38,95 Other molecular mechanisms targeted by non-pharmacological interventions in TBI include ferroptosis (in IF), autophagy via mTOR (in IF and CR), and metabolism via SIRT1 (in IF, CR, and KD). 60,61,63,64 Stem cells transplanted at the site of injury secrete factors such as neurotrophic factors, cytokines, and chemokines and regulate the function of surrounding cells.…”
Section: Pharmacological Aspects Of Non-pharmacological Interventionsmentioning
confidence: 99%
“…Additionally, applying a combination of pharmacologic and non-pharmacologic interventions is a possible means to address the pathophysiology of TBI and TBIassociated secondary damage, as non-pharmacologic interventions can target similar mechanisms of secondary injury through different targets in a multimodal approach to TBI treatment. For example, a hypothetical combination of mild therapeutic hypothermia and a free radical scavenger would target oxidative stress through decreasing ROS/RNS and upregulating anti-oxidative enzymes, potentially impacting oxidative stress at the hyperacute and early acute time periods [14,114]. While non-pharmacologic interventions are an appealing avenue for treatment of TBI, the mechanisms that underlie these interventions are not always well characterized.…”
Section: Future Directions In Multimodal Tbi Treatmentmentioning
confidence: 99%